Arsenic trioxide in the treatment of relapsed and refractory acute promyelocytic leukemia

被引:3
作者
Asou, N [1 ]
机构
[1] Kumamoto Univ, Dept Hematol, Sch Med, Kumamoto 8608556, Japan
关键词
acute promyelocytic leukemia; all-trans retinoic acid; arsenic trioxide; PML-RA alpha;
D O I
10.2169/internalmedicine.44.775
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:775 / 776
页数:2
相关论文
共 8 条
  • [1] Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
    Asou, N
    Adachi, K
    Tamura, J
    Kanamaru, A
    Kageyama, S
    Hiraoka, A
    Omoto, E
    Akiyama, H
    Tsubaki, K
    Saito, K
    Kuriyama, K
    Oh, H
    Kitano, K
    Miyawaki, S
    Takeyama, K
    Yamada, O
    Nishikawa, K
    Takahashi, M
    Matsuda, S
    Ohtake, S
    Suzushima, H
    Emi, N
    Ohno, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) : 78 - 85
  • [2] Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: Remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients
    Niu, C
    Yan, H
    Yu, T
    Sun, HP
    Liu, JX
    Li, XS
    Wu, W
    Zhang, FQ
    Chen, Y
    Zhou, L
    Li, JM
    Zeng, XY
    Yang, RRO
    Yuan, MM
    Ren, MY
    Gu, FY
    Cao, Q
    Gu, BW
    Su, XY
    Chen, GQ
    Xiong, SM
    Zhang, TD
    Waxman, S
    Wang, ZY
    Chen, Z
    Hu, J
    Shen, ZX
    Chen, SJ
    [J]. BLOOD, 1999, 94 (10) : 3315 - 3324
  • [3] Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring
    Ohnishi, K
    Yoshida, H
    Shigeno, K
    Nakamura, S
    Fujisawa, S
    Naito, K
    Shinjo, K
    Fujita, Y
    Matsui, H
    Sahara, N
    Takeshita, A
    Satoh, H
    Terada, H
    Ohno, R
    [J]. LEUKEMIA, 2002, 16 (04) : 617 - 622
  • [4] Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate
    Ohno, R
    Asou, N
    Ohnishi, K
    [J]. LEUKEMIA, 2003, 17 (08) : 1454 - 1463
  • [5] Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APE) .2. Clinical efficacy and pharmacokinetics in relapsed patients
    Shen, ZX
    Chen, GQ
    Ni, JH
    Li, XS
    Xiong, SM
    Qiu, QY
    Zhu, J
    Tang, W
    Sun, GL
    Yang, KQ
    Chen, Y
    Zhou, L
    Fang, ZW
    Wang, YT
    Ma, J
    Zhang, P
    Zhang, TD
    Chen, SJ
    Chen, Z
    Wang, ZY
    [J]. BLOOD, 1997, 89 (09) : 3354 - 3360
  • [6] Delayed recovery of normal hematopoiesis in arsenic trioxide treatment of acute promyelocytic leukemia:: A comparison to all-trans retinoic acid treatment
    Shinjo, K
    Takeshita, A
    Sahara, N
    Kobayashi, M
    Nakamura, S
    Shigeno, K
    Naito, K
    Maekawa, M
    Ohnishi, K
    Ohno, R
    [J]. INTERNAL MEDICINE, 2005, 44 (08) : 818 - 824
  • [7] United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia
    Soignet, SL
    Frankel, SR
    Douer, D
    Tallman, MS
    Kantarjian, H
    Calleja, E
    Stone, RM
    Kalaycio, M
    Scheinberg, DA
    Steinherz, P
    Sievers, EL
    Coutré, S
    Dahlberg, S
    Ellison, R
    Warrell, RP
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (18) : 3852 - 3860
  • [8] Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide
    Soignet, SL
    Maslak, P
    Wang, ZG
    Jhanwar, S
    Calleja, E
    Dardashti, LJ
    Corso, D
    DeBlasio, A
    Gabrilove, J
    Scheinberg, DA
    Pandolfi, PP
    Warrell, RP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (19) : 1341 - 1348